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We investigated whether the pattern ofT-cell recep-
tors expressed by T cells in inflamed psoriatic skin 
differed substantially from the pattern seen in T cells 
from the peripheral blood. A bias or restdction in the 
repertoire of T -cell receptors found in the lesional 
skin of different patients might imply that specific 
subsets ofT cells were causally associated with initi-
ating or maintaining the lesions. By using a polymer-
ase chain reaction-based assay of T-cell receptor 
/3-chain variable region mRNA, we found that the 
patterns of /3-chain mRNAs displayed in 14 samples 
of lesional skin or six samples of noninvolved skin 
were not significantly less diverse than the patterns 
found in matched peripheral blood samples. There 
was no evidence that the active lesions of multiple 
P soriasis is an inflanunatory skin disea. se characte1ized by keratinocyte proHferation and arrested maturation (Wron·e-Smith et nl, 1995), abnormalities in capillary structure and function (Parent et a/, 1990), and T -cell infiltration of the dermis and epidermis (Nickoloff, 
1991; Gtiffiths and Voorhees, 1996). The presence of activated T 
cells in lesions as well as the above- average associations with certain 
histocompatability locus antigen (HLA) class I markers (Russell et 
nl, 1972; Griffiths and Voorhees, 199.2; Elder et nl, 1994) suggests 
that psoriasis has some features of au autoin1mtme disease. Further, 
therapies that are intended to suppress T-cell activity such as 
cyclosporine (Mueller and Hermatm, 1976; Griffiths et nl , 1986), 
the IL- 2-diphtheria fusion toxin (Gottlieb et al, 1995), or anti- CD3 
or -CD4 antibodies (Weinshenker et al, 1989; Prinz et al, 1991; 
Rizova et al, 1994) demonstrate cHnical improvement, suggesting 
that T cells are crucial in the inflammation of psoriatic lesions. 
Activated T cells of both CD4 + and CDS + subtypes have been 
described in the dermis aud the epidermis in active psoriatic lesions 
of clu·onic plaque psoriasis or psoriasis vulgaris (Nickoloff, 1991; 
Chang et nl, 1994; Griffiths and Voor)1ees, 1996). Although T - cell 
proliferation is thought to occur in the skin, no specific triggering 
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patients showed overexpression ofT cells expressing 
one or a few T -cell receptor forms. The pattern of 
T -cell receptors displayed in clinically normal skin 
from normal control individuals showed about the 
same diversity as normal blood. While these results 
may not exclude either classical antigen or superan-
tigen-based T -cell activation mechanisms in active 
plaques, the absence of a simple pattern ofV/3 usage 
in different patients suggests than other aspects of 
T -cell biology including trafficking, proliferation, 
co-stimulation, or responses to cytokines must also 
be considered. Key words: T lymplwcyteslpsoriasis/RT-
PCR/repertoii'e aualysis. J Iuvest Dermatol 10!J:14-1!J, 
1997 
antigens have yet been identified. Nonetheless, based on the highly 
restricted T -cell repertoire observed in several murine autoimmune 
diseases, numerous groups have attempted to identify a similar 
phenomenon in human disease . The existence of such a restricted 
T -cell repertoire might imply that a common antigen or superan-
tigen is responsible for T cell activation and disease propagation. 
Prior stuc!ies of the number ofV/3-chains present in lesional T cells 
ag·reed that the T -cell repertoire was restricted in active lesions 
compared to the full repertoire in peripheral blood but disagreed 
about which Vf3-chains were the most abundant in different 
patients (Chang et al, 1994; Metmen et al, 1995). The study of 
Menssen et nl suggested that V/32 and Vf36 were most common, 
whereas Chang et al found that V{3 3.1, 13.1, and possibly V{3 17 
were the most fi·equently expressed in active lesions. 
Here, we re-examined this question by using the polymerase 
chain reaction for analysis of RNA isolated from full-thickness 
biopsies of active psoriatic lesions. Drawing upon the complete 
DNA sequence of the T-cell receptor genomic locus (Rowen et nl, 
1996), w e designed and validated a set of consensus oHgonucleotide 
primers that were specific yet all inclusive for 24 /3-locus-variable 
gene families . ln a group of carefully screened patients with plaque 
psorias is, we determined the distL;bution of the V(3 repertoire 
exhibited in lesional and nonlesional skin and compared it to the 
repertoire found in pe1;pheral blood. We also examined the V(3 
repertoire in the skin of normal individuals without active skin 
diseases. The results suggest that although the repertoire of V (3 
chain usage is restricted in the skin compared to the peripheral 
blood, in unrelated individuals with psoriasis there is no simple 
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pattern to the di versity ofV{3 chai11s utilized by the T cells present 
in active lesions. 
MATEIUALS AND METH ODS 
Collection of Samples and Patient Data Patients with plaq ue pso riasis 
were rccru.i ted from the general publi c in the Se,tde a.rea by newspaper 
advertising. Elig ibility criteria for en try into the study were assessed with a 
return telephone c" ll and then with " short office visit in w hk h informed 
consent W;JS obtained "nd the cl inical d iagnosis of pso1iasis was confirmed. 
If stud y subjects en ro lled i11 the study and bad been using systemic o r top ical 
treatm ents for pso riasis exclusive of bland emollients, they were instructed 
to discontinue the ir n-ca ttncnts and return in 2 \Vk fo r skin and blood 
sampling. Otherwise, the skin and blood sampling was performed at this 
visit. Vo lunteers who had a history o f infection with hepatitis B or C, or 
human i.Jnmuno de fi ciency virus type J , o r w ho had pustular, erythrodermic, 
or acute gutta te psoriasis were excluded liom the study. Two full-thi ckness 
6-rnrn diatne tcr punch biopsies were taken lion1 ~t n active les ion, and one 
biopsy w as ta ken lio m lesion-free skin . The diagnosis of psoriasis was 
independently confirmed by histo logic exam ination of thin sections cut 
fro m one of the lesional biopsy samples. l-I LA antigen freq uencies at the A, 
B, :utd C loci w ere determined fi:om pe ripheral blood by using se rologic 
methods. N o rma l skin was o bta ined fro m volun teers by shave biopsy of a 
·1 X 2 ern area _ 
RNA Purification and eDNA Synthesis RNA was isolated from 
les ions or lesion-free skin by homogenizatio n of fi·eshl y isolated tissue with 
a motor-driven ho mogenizer in 1 m l Tri R.eagent (Mo lecular R esearch 
Center , C incinnati OJ-I) accordu1g to the directio ns of the m"nufacturer. 
RNA was isolated liom normal skin after preparing a ce ll suspension . After 
incubation in Dulbecco's modified Eagle's medium (GIBCO BRL, Gaith-
ersburg, MD) made l m g per m l in co llagenase-d ispase (Boehringer, Cat. 
269 638, lndianapoljs, IN) a total ce ll suspension was prepared from shave 
biopsy samples by "brmion and tl ltration through a nylon scree n. Recovered 
cells (0.3 to 1.0 X 1 0") were washed in phosphate-b uffered salin e and lysed 
in l m l Tri R eagent, and RNA was prepared as described above. T he 
in tcgdty of all RNA samples was assessed after denatur,.tion in 40')1,, 
dimethyl sultoxidc and electrophoresis in 1.2% agarose ge ls (Sea.Kem LE, 
FMC Corp., H.._ockJand, M E) in 0.045 M T ris(hydro>.J'meth yl)aminorneth-
'tne-bo ratc (pl-1 8.3), 0.001 M e th ylenediamine ten:aacetic acid. 
In addition, RNA was iso lated from periphend blood-deriv i!d mononu-
clear cells. B riefly, mononuclear cell s were isolated on FicoLI-1-I ypaque 
gradients from peripheral blood (1 0 m l) that had been diluted 3- fo ld w1th 
phosphate- bulfercd saline. Mo nonuclear cell s (b ulfy coats) were washed 
twice in phosphate-buffered sa line and lysed in 1 rnl T ri Reagent, and to tal 
cell RNA was prepared as described above. 
First-su·and eDNA was syn tl1csized trmn upto about 3 J.Lg of total cell 
l'l..:NA from ski n o r ·1 J.Lg of total cell RNA fro m peripheral blood ce lls With 
the SuperScript II RNase 1-l - reverse tra nscriptase system (GJBCO BRL) m 
20 ,u.l rea ctions. For V f3 reper toire an alysis, first-strand eDNA was spectfi -
ca lly primed with the Ca-R.T2 plus C J3-cDNA2 primers (Table I) , wb1ch 
w ere present at fma l concentrations of250 nM. First-strand eDNA sa mples 
were d iluted w ith 180 J.Ll of w ater bctore V f3 repertoire amdysis. T he ability 
of samples to support ampli fication of eDNA was tested with control 
amplifications to a portion of the a-ch<tin constant region mRNA using the 
Ca-Choi-5 ' and Ca-cDNA-2 primer pair. 
Analysis of V/3 Repertoire For VJ3 repertoire analysis of fir st-strand 
eDNA samples that were transcribed fro m ski11 or blood cells, polym erase 
ch<tin 1·eaction amp li fi cations contained l p.l of specifically primed tlrst-
strand eDNA, a primer from the {3-locus constant region (CJ3-Lulu), and 
one of th e 24 {3-locus vadable-region consensus primers V/31 through V/324 
(Table 1). As an iute rnal control the reactions aJso contained the a -gene 
constant 1·egion primers m en tioned above. T he 25-,u.l reactious were 
ampHfted for no m ore than 35 cycles (skin) or 30 cycles (blood) With a 
p rogram o f 94°C 30 s, 60°C 45 s, 72°C for 90 s in a Perk.in-Elmer 9600 
po lym erase chain reactio n machine. Seven mjcroliters of these reactions 
were subjec ted to e lectmpho resis on 2% <~garose gels for 150 volt-ho.urs. 
T h e DNA was blotted o nto Hybond N + m embranes (Amersham, Arlmg-
ton H eigh ts, lL) and hybridized with a mixture of 0.5 X 10 6 dpm 
32P-labe led oligonucleotides specific fo r the /3- and a -chain constant regiOns 
(C/3-F o r Ca- CAR: Table I) per m l overnigh t in 0.060 M T ris(hydro>.)'m-
cthyl)arninornethane-1-ICI pH 8.0, 0.002 M ethylenediamine tetraacetl c 
:teid , SX Denhardt's , 6 X SSC, 0.1% N-laurylsarcosine, and 0.5% NP-40 . 
Membranes were washed in O.S XSSC <Jt 45°C three ri mes , <Wei au toradio-
grams were quantitated with the aid of a Phosphorlmager (Molecular 
Dynamics, Sunn yva le, CA) and the lmageQuant software. 
Table I lists t he se t of conseusus prin1ers that were used in tlu s study to 
amplj f)r transcripts fro m the 24 djffere nt V f3 gene fami li es. Tria l amplifica-
Vf3 R.EPER.TO IKE IN PSO lUAS IS 15 · 
Table 1. Oligonucleotide Primer Sequences 
N:mw 
Vfl I 
V/3 2 
Vfl J 
V/3 4 
V/3 5 
V/3 6 
V/3 7 
V/3 8 
V/3 9 
V{3 10 
V/311 
V/31 2 
V/3 13 
V/3 14 
V/3 15 
V/3 16 
V{3 17 
V{3 18 
V/3 19 
Vfl 20 
V/3 21 
V(3 22 
V{3 23 
Vf3 24 
C(:l-cDNA-2 
C/3-LuJu 
C{3-F 
Ca-RT-2 
Ca-Choi-5' 
Ccr-cDNA-2 
Cet-CAR 
Sequence 
GCTCCCCTAGGTCTGGAGACCTCTCT 
CCACATACGAGCAAGGCGTCGA 
TCCAGGATATGGACCATGAAAATATGTTC 
CAACCTGGACAGAGCCTGACA 
CTGATCAAAACGAGAGGACAGCA 
CAGGTGCTGGAGTCTCCCAG 
ACCGGAGCTCATGTTl'GTCTACA 
TCTGGTACAGACAGACCATGAT 
ACCTAAATCTCCAGACAAAGCT 
GAAGAAGAGCTC.~AGTTTTTGGTTTACTTT 
TGATATCACCTCATCCACTATTCCTATGGA 
GACAGAGGAT1TCCTCCTCACT 
CACTGCGGTGTACCCAGGATATGA 
GGGCTCGGCTTAAGGC.'\GACCTAC 
GGCCTACGGTTGATCTATTACTCCTT 
TGTGACCCAATTTCTGGACATGATAAT 
GAACAGAATTTGAACCACGATGCC 
AGCCCAATGAA.AGGACACAGTCAT 
ACCCCCGAAAAAGGACATACTT'TT 
GAGGGAACATCAAACCCCAACCTA 
GATTCACAGTTGCCTAAGGA 
GTCCCCATCTCTAATCACTTATACT 
TCCAGGTCAGGACCCCCAGTT 
TGGTACCAGCAGAAGTCAAGT 
CCCTAGCAAGATCTCATAGAGGAT 
TTCTGATGGCTCAAACAC 
GTTCCCACCCGAGGTCGC 
AGGTn-rGAAAGTIT AGGTTCG 
GAACCCTGACCCTGCCGTGTACC 
ATCATAAATTCGGGTAGGATCC 
TCAGATTTGTTGCTCCAGGCCA 
llefcn!nc:c 
H all & Fino , 1992 
Bragado el nl, 1990 
H all & Finn. 1992 
Hall & Finn, 1992 
Hall & Finn, 1992 
Gc.ncvce ef nl1 1992 
Gl!nevcc et ol, J 992 
Bragado et al, 1990 
Bragado e1 nl, 1990 
Bragado e/ nl, 1990 
Hand el al, 1993 
Hand e/ a/, 1996 
C hoi el a/, 1989 
Choi el a/, 1989 
tions revealed that previous sets of primers intended (or V f3 repertoire 
analysis showed an uneven abilj ty to amp li fy V f3 mRNA from periphera l 
blood, w hen tested under the same conditions (Cho i e/ a/, 1989; Bragado et 
nl, 1990; Genevee et nl, 1992; H all and Fi1m, 1992; Nishimura e/ nl, 1994). 
After empirical comparisons of the dilfercn t published primers , we retained 
some published pr im ers, m o dified othe rs, and designed several new pdmers 
to achieve a panel that offered high relative priming efficiency while 
retaining selec ti vity for a given V/3 gene family , w hether that family 
contai.J1 cd one or mruty m embers. 
Assay Validation Stndies In va ljdation studies, the set of primers shown 
in Table I amplified bands of the appropriate size fro m periphera l blood 
eDNA (data not shown), and the identity of the ampljfi cation products was 
confirmed by DNA sequence ;mal ysis. The V/3 transcripts expressed i.J1 
Jurkat cell s were studied as another tes t of this primer set and the meth od i.J1 
general. One microgram of total cell RNA was reverse transcribed, and the 
ftrst-su·and eDNA was aliquoteci and su bj ec ted to amp lj fi ca tio n with the 24 
V f3 consensus pcimers as described. V/3 8 was the on l)' V/3 mR.NA detected; 
signals from the o ther V(3 m.RNAs w ere less than 10- 3 to 10- 4 rimes the 
level ofV/3 8 signal (data not shown). V(3 8.1 was expected as the only V/3 
mR.NA detected i11 thi s clone of the Jurkat cell line (Weiss and Stobo, 
1984) . One and , less frequently, two V(3 mRNAs were detected in a set of 
more than 50 clonal primary T - cell lines that had been raised after 
allogeneic stimulation (data not shown) . When total ce ll RNA was 
analyzed fro m peripheral blood mononucl e<~r ce l.l s, transcripts fi·om all V f3 
fi1milies were detected (dnta not shown). 
When analyzing sk.in cDN A samples, a minimum number o f amplifi ca-
tion cycles was used, to maintain the proportionali ty of the amplifica tion 
product with the level of target sequcuces in the input eDNA. In order to 
control fo r sample to sample variation and to facilitate comparison o f the V (3 
repertoire in the skin with that of the b lood, the signal tor a given V/3 was 
corrected for background and then normalized to the Cn signal produced in 
the same tube to give the relative V/3 expression. That relati ve V J31evel was 
th en expressed as a percentage of the total expression for aU 24 V f3 ml~ As 
observed for that sample (Akolkar e/ a/, 1995). 
RESULTS 
HLA Class I Serotype Analysis We fi rst determined th e 
l-ILA- class I serotypes of 52 patients having a confirmed diagnosis 
of psoriasis vulgaris. T he diagnosis was confmned by histologic 
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F igure 1. HLA class I serotype frequencies in psoriatics and normals. Phenotypic antigen frequency scores from the patients with psoriasis (N 
52) are represented by black bars; scores fro m controls (North American Caucasians) are shown with hatched bars. Pmtcl a, HLA-A antigen freq uencies; paue/ 
/J , HLA-B antigen frequencies; paucl c, HLA-C antigen frequencies. T he normal antigen frequencies for the l-ILA-A, -B, and -Cw1 through -Cw6 and -Cw8 
were taken from the Eighth lnternatioual Histocompatibility Workshop. The data for HLA-Cw7 for US Caucasians was taken from data presented at the 
Eleventh International Histocompatibility Workshop. 
examination of full - thickness biopsies. Dat~ from the HLA-A, -B, 
and -C loci are sh own in Fig 1. Our patients showed striking 
elevations ofHLA-Al as well as HLA-B 17 + B57 (measured togeth-
er), and possibly -B37 and -B39, all of w hich h ad also been n oted 
previously (Asahina et al, 1991; Griffi ths and Voorhees, 1992; E lder 
et al, 1994). As expected , HLA-Cw6 was al so elevated . T llis locus 
was nearly three times as frequ ent in our study group, as it was in 
our reference population. 
A Semiquantitative Assay ofV/3 mRNA Levels We refined 
a reverse transcriptase-polymerase chain reaction- based method to 
establish t he repertoire ofT - cell recep tor J3-chain variable region 
mRNA that was isolated from full-thickness biopsies of lesional or 
nonlesional skin and compared it to th e VJ3 mRNAs displayed in 
peripheral blood. Previously described primer sets exllibited tmac-
ceptably large variations in amplification efficiency in o ur control 
experiments. Thus, we developed a panel of oligonucleotide 
primers from published reports, as well as from o ur own designs, 
a 
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Figure 2. V/3 usage in lesional skin and peripheral blood from 
patient P7873: primary data. First-strand eD NA from lesional skin (pauel 
a) or pct;pheral blood (panel b) was aliquorted and amplified with primers 
specifi c for a 590-bp fragment from the TCR a-locus constant region (Ca) 
as an interna l control or primers that amplified fragments from 3 75 to 200 
bp derived from V {3 families 1 through 24. Amplification products were 
fractionated on a 2% agarose ge l in lanes 1 through 24, and the ge l was 
blotted and probed with a or {3 constant region o]jgonucleorides that had 
been labeled with 32P by phosphorylation. 
th at specifically amplifi ed mRNA transcribed from all the func-
tional family members (Rowen ef nl , 1996) of th e 24 different 
families of J3-chain variable regions with maximal efficie ncies. In 
addition, all V/3 amplifications included an internal control (Ca) , 
which allowed sample- to-sample comparison . Nonetheless, we feel 
that the most reliable conclusions ab o ut possible restri ctions on th e 
V/3 repertoire in ps01;asis in these studies are obtained by compar-
ing the level of a particular VJ3 in one sample (skin) relative to the 
le vel of th at V{3 in a reference tissue (peripheral blood). T he 
relative expression level of diiferent V J3 families in th e same sample 
is semi-quantitative at best due to inherent differences in primer 
e-fficiencies. Each sample was evaluated after reverse transcription 
and amplification with prin1ers specific for each of the 24 different 
VJ3 gene families. The amplification products from each sample 
were then quantitated independently twice, an d those resul ts were 
averaged. 
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Figure 3. Quantitation ofV/3 usage in lesional skin and peripheral 
blood from patient P7873. Data from the gel shown i.n Fig 2 and a 
rcp]jcatc gel were averaged, and V f3 expression in lesional skin was plotted 
with solid !Jars as a percentage of the total V {3 expression observed in the 
sample. Opeu bars denote V {3 expression in peripheral blood . 
VOL. 109, NO . 1 JULY 1997 
I V~ famil~ 
1 2 3 4 5 6 7 8 9 10 11 ! 12 13 14 15 16 
I HLA 10 
I Cw6.Cw6: 04161 8S8:S lS88! 
I Cw6.Cw6: F1442 
I Cw6. Cw6 · F2370 
--
I Cw.§,cwa; 0064 S38S 
-
I Cw6.Cw4: P1620 
-
I Cw4 .Cw7: 63583 
~"~'" ~ m I Cw2.Cw2: H4820 :ms: 
I Cw5 .Cw7 · L7497 lS8&' 
I Cw7 ,Cw7; M8924 
• 
I Cw3,Cw7: P7873 
I Cw7,Cw7; R6409 
I Cw3.Cw7: V78BO I 
-
~C\Y_;t V~87_6j 
-
~ 
The V/3 Repertoire in Lesional or Nonlesional Skin Figure 
2 compares the V/3 repe rtoire of lesional skin w ith the repertoire 
found in pet;pheral blood of one patient with psoriasis. In the 
lesional skin , mRNA was readily detected from a considerable 
number ofV/3 genes, including V/3 families 1 thro ugh 17, 19, and 
21 through 24 (Fig 2a) . T lus pattern of expression is similar to the 
large number of V/3 mRNA fa milies that were found in the 
peripheral blood of this patient (Fig 2b). Some V f3s were overex-
pressed in the lesional skin compared to the peripheral blood 
including Vf3s 1, 5, 6, 9, 11, 12, 19, and 21 as shown in Fig 3 in 
which the re lative V f3 expression in the skin is plotted next to the 
expression in the blood. 
We next asked whether different patients with chronic psoriasis 
might exhibi t the sam e pattern of V/3 utilization. Figure 4 com-
pares th e V f3 utilization from the ski n lesions of 14 patients. mRNA 
transcribed from those V f3 families that w e re expressed in the skin 
at twice the level as they were expressed in the blood are denoted 
with shading. Although some V/3 ml~As, such as V/3 2, 5, 9, 12, 
or 21, were overexpressed in three or four of the patients we 
studied, no V/3 mRNA was consistently overe:-.:pressed in a simple 
majority of o ur patients. We found no evidence in the patients we 
studied for consistent overexpression ofV/3 2 or 6 (Menssen eta/, 
1995) or V/3 3 and 13 (Chang et a/, 1994) as had been reported 
previously. T hus, although the pattern ofV/3 mRNA expression in 
active psoriatic lesions we studied differed from the pattem in the 
peripheral blood and could therefore be called 'restricted ,' we 
could discern no simple pattern to the V/3 u tilization in 14 patients. 
In some cases the pattern of V/3 mRNA recovered from no nle-
sional skin was consisten t with an extreme restriction in tl1e 
Cet 
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Figure 5. V{J usage in nonlesional skin and peripheral bloorl in 
patient V7880. First-strand eDNA from nonlesional skin (pa 11cl a) or 
peripheral blood (pa 11el b) was aliquotted , ampli fied, and fi·actio nated as 
described above in the legend to Fig 2. V (3 usage in the lesional sample from 
this patient is given in Fig 4. 
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Figure 4. Quant.itation ofV/3 usage in 
14 patients with psoriasis. V (3 usage was 
measured in 14 patients as shown above in 
Figs 2 and 3. V {3 expression was plotted 
with a hatched rectattgle if its level in the skin 
exceeded twice its level in peripheral blood 
and S'X, of the tota l. If expression in tl1e skin 
exceeded twice irs level .in periphera l blood 
and 1 O'X, of the total, it was plotted with a 
solid recta11gle. The inferred HLA type of 
each patient (determined serologica lly) is 
given beside the patient ID codes. 
repertoire of T cells. V {3 8 and 13 were overexpressed in the 
nonlesional skin of one patient compared to their respective levels 
in peripheral blood T cells, and most other V/3 mlWAs were barely 
discenuble, as sh own in Fig 5. T he image in Fig 5 was quantitated , 
and V {3 e>.:pression in the nonlesiona.l skin was plotted next to 
expression in the blood in Fig 6. V/3 8 accounted fo.r 26.7% of the 
tota l V/3 expression in the nonlesional skin, which was just less than 
twice its percentage (14.3%) in the peripheral blood , and the level 
ofV/3 13 was more than 5 times highe r in the nonlesional skin than 
in th e peripheral blood. Although the level of recovered RNA fi·om 
nonlesional skin was lower than fi·om lesional skin, data from si.-x 
patients again showed a restricted pattern ofV/3 mRNA expressio n 
(Fig 7) . No V f3 family was overexpressed in more than two of the 
six samples, and again we fo und no simple pattern to the 11 
difl'erent V f3 families that were overexpressed in the nonlesional 
skin of different patients. 
The V/3 Reperoire in Normal Skin We also studied the V/3 
repertoire in normal skin samples from eight donors without 
psoriasis . Total cell RNA was prepared from shave biopsy sa mples. 
Overall the pattern ofV/3 usage in normal skin was quite similar to 
a normal blood profile : m ost V f3 f<unilies were present. V f3s th at a.re 
expressed at lugher l.e vels in pe ripheral blood were readily detected 
in the skin, such as V f3 families 2, 4 , 5, 6, 8, 12, and 21 (Fig 8) . 
DISCUSSION 
T hi s study was in tended to test the h ypothesis that the repertoit·e of 
T -cell antigen receptor structures might be highly restricted in 
psoriatic lesio ns, compared to the more diverse proftle of receptors 
displayed by peripheral blood T cells. This possibility is suggested 
by restrictions in the T - cell repertoire that were i•utially reported 
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Figure 6. Quantitation ofV{J usage in nonlcsional skin and periph-
eral blood in patient V 7880. Data from the gel shown in Fig 5 and a 
replicate gel were averaged, and V (3 expression in nonlesional skin was 
plotted with solid bars as a percentage of the tota l V (3 expression observed in 
the sample. Ope11 bars denote V (3 expression in peripheral blood . 
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Figure 7. V (3 usage in nonlesional 
skin in six patients w ith psoriasis. V/3 
usage data from Fig 6 for patient V7880 
and five additiona l patients was plotted as 
described above for· nonlesional skin (Fig 
4). V f3 express io n was plotted with a 
lr alclr etl recfallgle if its leve l in the skin ex-
ceeded twice its level in the peripheral 
blood and 5'Yu of the total in the sample. If 
expression in the ski.n exceeded twice its 
level in peri pheral blood and 1 0'% of the 
total, it was plotted with a solid recfallgle . 
Tbe in ferred HLA type of each patient 
(determined sero logica lly) is given beside 
the patient ID codes. Note that for patient 
V7880, the leve l of V/3 13 in the skin was 
more than 5 times its level in the blood and 
was rhus plotted in Fig 7. T he level of V f3 
8 was o nl y 26. 7'!1,,/14.3% = L 87 times 
greater in the skin than in the blood and 
rhus did not exceed the somewhat arbitrary 
criterion of 2-fo ld ovcrexpression. 
1 2 3 4 
HLA ID 
I~;___K6049 
ews,ew6; AB974 
ew6,Cw7· A6424 
ew2 Cw2· A5976 
ewe ewe· P1e66 
Cw3 Cw7· V7eeo 
for autoimmun e disorders such as multiple sclerosis and by the 
find in g that a particular clonotype ofT cells can transmit experi-
m ental autoimmune encephalomyelitis in adoptive transfer exper-
iments w ith rodents (Schluesener and Wekerle, 1985; Hafler el nl , 
1996). T he existence of a restricted T -cell repertoire in psoriatic 
lesions mjght suggest that stimulation of T cells by a common 
antigen or superantigen is important to di sease pathology. If a 
restricted T -cell subset were usually associated with psoriasis, it 
could become th e target of immunotherapy . Although nonspecific 
immun os uppression is the intent of some current therapies, a 
selective immunotherapy directed at a known anti gen or T -cell 
receptor structure might be superior. 
In the data presented here, although there was eviden ce for 
modest overexpression of certain V{3 mlWAs in psoria tic lesions 
compared to peripheral blood, there was no consistent pattern of 
V{3 expression in aU or even in a maj olity of the patients we studied . 
Because antigen presentation is major histocompatibility complex-
restricted, we also asked whether the T -celJ repertoire might 
correlate with an major histocompati bili ty complex haplotype that 
had been previously associated with psoriasis. As was the case for 
the genera l population of patients, no particular V {3 mRNAs were 
overexpressed in the subset of sa mples that were derived fro m 
patients who carried one or two copies of the HLA-Cw6 allele. 
Likewise, there was no apparen t pattern to the restriction in T-cell 
receptor repertoire in nonlesional skin, even though individuals 
occasionally displayed extremes of restriction as shown in Fig 5. 
T he pattern of mRNA expression noted in Fig 5 suggests that we 
would not have missed restricted repertoires in other samples, h ad 
they been present. 
ln normal skin the apparent V {3 repertoire was to a first 
approximation similar to th at in peripheral blood, beca use in typical 
samples mRNA fo r more than 18 different V {3 gene families was 
readily detected. W hereas Vf3s 2, 4, 5, 6, 8, 12, <md 21 were 
overexpressed in four or more of the e ight normal skin samples, 
Figure 8. V/3 u sage in eight normal skin 
samples. V/3 usage was measured in shave 
biopsy specimens of normal skin. Vf3 expres-
sion was plotted w ith a lwtclr ed rccfallgle if the 
level exceeded 5% of the total V f3 expression 
in the sample or w ith a solid rectmrgle if its 
expression exceeded 1 0% of the tota l in the 
sample . A repertoire anal ysis fro m a normal 
peripheral blood sample is given in the bot-
torn row for co mparison. 
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further studies are necessary to determine whether this represents a 
significant difFeren ce from the peripheral blood profile. 
ln these studies the repertoire of Y {3 mRNAs in the skin was 
judged relative to the level of the sam e V {3 sequence in the blood. 
Overexpression was noted, somewhat arbitrarily, if the level ob-
served in th e skin was twice that in the blood and more than 5% or 
10% of the total V{3 expressed in the sample (Akolkar et nl , 1995). 
T h ese data were developed with the sa me primers, and aU amplj-
fications a11d subsequent quantitation steps were don e in parallel , 
minimizing potential sources of error. We avoid argm11ents based 
on relative levels of diffe rent V{3 mRNAs in the same sample, in 
view of the difficulty in designing a set of 24 different consensus 
primers that amplify different sequences with the same absolute 
efficiencies. 
Our results agree with those of Boehncke ef n/ (1995) and 
Vekony et nl (1997) in which oruy slight restrictions on the V {3 
profi le in psoriatic RNA compared to peripheral blood were found. 
Boehncke et nf (1995) examin ed ten chronic plaque psoria sis 
samples for restrictions of the V a as well as for the V {3 repertoire. 
Typica lly, the psoriatic lesions exhibited 80% of the repertoire of 
the peripheral blood , and no .intedndividua l pattem of V {3 use 
between patients was noted. ln the studies ofVekony et al most of 
the ten patients studied showed similar repertoires ofV{3 mRNAs in 
psoriatic skin and peripheral blood . V{3 2 and 6 were overexpressed 
in on ly two of the ten patients, in contrast to the results of M enssen 
ef nl (1995), in which these V{3s were found to be overexpressed in 
a majority of both the normal as well as the psoriatic skin samples 
they exa mi11ed. It has also been claimed that V{3 3 and 13.1 were 
overexpressed in activated CDS+ T cells in a majority of psoriatic 
lesions (C hang e/ nl, 1994). N either the current results nor those of 
Boehncke el a/ or Vekony et n/ reproduced these findings. Whether 
the rufferences result fi-om biopsy difie rences (full-thickneSS 1/C/"S//S 
shave), the enrichment of specific T-cell subsets by flow cytometry 
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(C han g ef a/ , 1994), or other methodologic diffe rences such as the 
use of diffe rent primer sets rem ains un clear. 
Our results sugges t that the re may be no common disease-
specific expanded T - cell clon es that aJ'e associated with active 
lesions in different patients. T he absen ce of such clones sugges ts 
that therapies directed against particular T -cell receptors such as 
T -cell vaccines or small m olecule anatagonists directed against the 
lesion al T cells observed in one patient are unlikely to be effective 
in o ther patients that may lack these clones. Absence of a predom-
inant T - cell clon e in different individuals, however, does not 
necessarily permi t the conclusion that either superantigens or 
con ventional antigens are not important in the initiation of disease. 
A skewed Vf3 repertoire might have been overlooked in our study 
if, for example, superan tigens or conventional antigens activated 
key T - cell subsets qui te early, well before the fo rmation of a 
clinicalJy observable plaque. Al ternatively, processes such as apo-
ptosis or T - cell traffi cking or recnutment couJd have diluted or 
reduced the number of key activated T cells to ben eath the average 
background or th e lower detection limit in our study. In addi tion, 
sm all numbers ofT celJs activated by a conventional antigen might 
evoke T celJs that expressed multiple Vf3 chains if, fo r example, 
multipl e antigenic peptides were deri ved fi·om th e sam e protein or 
if different Vf3 chains interacted with the sam e peptide. Indeed , 
streptococca l antigens have been implicated as initiators of guttate 
psoriasis (B aker et a/ , 1993; Lewis eta/ , 1993) . Whether a common 
antigen or superantigen will ultim ate ly be identified as leading to 
the ini tiation of psoriasis rem ains an im portan t qu estion, but th e 
diversity ofT cells we observed in associa tion with chronic lesions 
in the current study suggests that the design of a targeted immu-
notherapy based on a single Vf3 isofonn m ay be prem ature. 
Because the T - cell infiltrate appea rs to be important for th e 
pathogen esis of psoriasis, it is of in terest now to focus on other 
aspects of this response. Both C04 + and CO S+ T cell subsets are 
associa ted with lesions, and these cells are not uniformly distributed 
be tween the epidermis and dermis (Valdimarsson eta/, 1986; Baker 
et a/ , 1984; Ch an g et nl, 1994) . In the current study, m any of the V {3 
chain s that w ere overexpressed in normal skin (Vf3s 2, 4, 5, 6, 12, 
21 , and possibly 22) w ere not represented to the sam e degree in 
either lesiona.l or nonlesional samples from patients w ith pso riasis. 
While it is tempting to speculate that this apparent differen ce could 
re fl ect an imbalance of a process that influen ces the number o r 
diversity ofT cell s such as clon al expansion , activation, or ap opto-
sis, the number of in fo rmative R.N A samples we studied was far too 
small to d raw any fi rm conclusions. R ecovety ofT cells fro m the 
dermal and epidermal compartments combined with frac tionation 
of the cells into C D4 + or cos+ subsets, with or w ithout m arkers 
of activa tion or th e early stages of apoptosis, could help test this 
possibili ty. T he role of the T cell (along with cells th at present 
antigens or co-stimulato ry signals) in disease pa thology, the nature 
of the cytokines produced , and the responses to th ese cytokines will 
be fi·ui tful areas of discovery. Perhaps most important will be the 
molecular disassembly of those interac tions that initiate and regu-
late T -cell ac tivation in the lesion a! skin . 
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D r. R oss Bright (Psoriasis R esemr/1 Imtitute), Julie Tas11 arly, a11d Fred R alllsde/1 who 
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